Bhutanese locals generally support this fee because it aligns with their principles of Gross National Happiness, prioritizing ...
The Meeting Materials, the Schedule 1 Announcement and the Appendix are available for viewing on the Company's website at www.cornishmetals.com and on its SEDAR+ profile at www.sedarplus.ca.
Delivered Q3 2025 revenue of $83 millionQ32025 non-dermatologic revenue increased by 67% over Q32024Q32025 total test reports ...
NYSE: VOYG] ("Voyager" or the "Company"), today announced financial results for the third quarter 2025. Delivered net sales ...
Federal Agricultural Mortgage Corporation ( AGM) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST " Keefe, Bruyette, & Woods, Inc., Research Division Good afternoon, ladies and gentlemen, and ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
Massif Capital's Q3 2025 Real Assets Strategy returned 36.1% net, YTD 41.5%, with strong Alpha and Sortino. Discusses gold, ...
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...
Eagle Hills,' one of the leading global real estate development companies, announced the opening of its new showroom in the ...
The Business & Financial Times on MSN
Cases in Finance – Episode 9: Understanding mobile money: The hidden engine behind every MoMo alert
MENSAH What if the money in your MoMo wallet, the balance that makes you feel rich, isn’t real at all, but just a digital ...
Building on insights from the BA Zone, Phase 2 will broaden exploration scope to include the LPA and BF Zones. This phase is designed to investigate a substantial ~375,000 ounces of gold endowment, ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for ... 91% MRD negativity in the 12-patient, BCMA-naïve cohort treated at the RDE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results